Objective metrics of patient activity: Use of wearable trackers and patient reported outcomes in predicting unexpected healthcare events in cancer patients undergoing highly emetogenic chemotherapy.

Authors

null

Alexander S. Martin

University of Southern California, Los Angeles, CA

Alexander S. Martin , Roger Wilson Boles , Luciano Nocera , Anand Kolatkar , Marcella May , Zaki Hasnain , Naoto T. Ueno , Sriram Yennu , Angela Alexander , Aaron Mejia , Ming Li , Frankie A. Cozzens Philips , Paul K. Newton , Joan Broderick , Cyrus Shahabi , Peter Kuhn , Jorge J. Nieva

Organizations

University of Southern California, Los Angeles, CA, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, University of Texas MD Anderson Cancer Center, Houston, TX, LAC/USC, Los Angeles, CA, NCI, Center for Strategic Scientific Initiatives, Bethesda, MD

Research Funding

NIH

Background: Functional status and predictors that identify those cancer patients at risk for unplanned hospitalization can have broad implications for the health care system and clinical trials. We evaluated the feasibility of monitoring physical activity (PA) using wearable activity trackers in cancer patients on highly emetogenic chemo as well as potential correlations between PA and unplanned healthcare events (UHE) and ECOG scores. Methods: This study was conducted as a multi-institutional single arm observational clinical trial of 65 patients with solid tumors undergoing highly emetogenic chemo based on Hesketh classification. We measured PA by analyzing daytime hourly metabolic equivalents (1 MET = resting metabolic rate) from 10 AM - 7 PM over 60 days via Microsoft band 2. Patient reported outcome data was collected using smartphone apps. UHE were collected by review of medical records over the 60 days of band wear plus 90 days of clinical follow up. Results: Data was successfully captured from 41 of the 65 activity trackers. Patients were compliant with wearing the activity trackers for > 7 of 9 total hrs on 67.7% of study days. Only 9 out of 41 patients exhibited > 60 hours of non-sedentary activity, defined as > 1.5 METs, over the 60-day band wear period. Mean step counts/day were similar between higher and lower PA groups at 2564 steps/d and 2261 steps/d respectively. 9 patients with > 60 hrs of 1.5 METs had significantly fewer UHE compared to the 32 patients with < 60 hrs of 1.5 METs (p = 0.02). The physician reported ECOG scores had no correlation with PA or UHE. Conclusions: In solid tumor patients undergoing highly emetogenic chemo regimens, activity trackers are feasible and identify those patients with a profile of lower activity that predicts UHE. Incorporation of activity trackers has the potential to identify patients who are at need for interventions to prevent hospitalization and may also predict the subset of patients enrolled in clinical trials who are more likely to record serious adverse events.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Health Services Research, Clinical Informatics, and Quality of Care

Track

Quality Care/Health Services Research

Sub Track

Outcomes

Citation

J Clin Oncol 36, 2018 (suppl; abstr 6519)

DOI

10.1200/JCO.2018.36.15_suppl.6519

Abstract #

6519

Poster Bd #

345

Abstract Disclosures